Skip to main content
Erschienen in: Infection 3/2011

01.06.2011 | Clinical and Epidemiological Study

Prolonged duration of operation: an indicator of complicated surgery or of surgical (mis)management?

verfasst von: P. Gastmeier, D. Sohr, A. Breier, M. Behnke, C. Geffers

Erschienen in: Infection | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to investigate whether a prolonged operative time should be regarded as an indicator of quality problems in operating rooms or as patient-specific risk factors when analyzing surgical site infection (SSI) rates.

Method

Data from the SSI component of the German national nosocomial infection surveillance system (KISS) were used to address this question. Eight procedure categories tracked by at least 30 departments participating in KISS were included in the analysis, namely, hip (2 types) and knee prosthesis, breast surgery, hernia repair, C-section, cholecystectomy and colon operations. Various multiple logistic regression analyses were performed for each procedure category to predict duration of operation. Patient factors (sex, age, American Society of Anesthesiologists score, wound contamination class) and hospital factors (hospital status, size, annual volume) were considered. The area under the receiver operating characteristic (ROC) curve was used to evaluate predictive power including patient- and hospital-based factors.

Results

A total of 253,454 operations were included in the analysis. In general, the predictive power of the model including all variables for the different procedure types was relatively low (C-index range: 0.57–0.63) and not much higher than that of the models including only patient-based or only hospital-based variables, respectively. The predictive power for the duration of operative time based on the model including only hospital-based variables was as good as or better than that of the model including only patient-based factors.

Conclusion

Duration of operation is at least partially determined by hospital factors and, consequently, should be used as a quality indicator to compare SSI infections between hospitals, rather than being used as a patient factor to adjust comparisons between hospitals.
Literatur
1.
Zurück zum Zitat Haley RW, Culver DH, Morgan WM, et al. Identifying patients at risk of surgical infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985;121:206–15.PubMed Haley RW, Culver DH, Morgan WM, et al. Identifying patients at risk of surgical infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985;121:206–15.PubMed
2.
Zurück zum Zitat Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infections rates by wound class, operative procedure, and patient risk index. Am J Med. 1991;91[Suppl 3B]:152S–7S.PubMedCrossRef Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infections rates by wound class, operative procedure, and patient risk index. Am J Med. 1991;91[Suppl 3B]:152S–7S.PubMedCrossRef
3.
Zurück zum Zitat Brandt C, Hansen S, Sohr D, Daschner F, Ruden H, Gastmeier P. Finding a method for optimizing risk adjustment when comparing surgical-site infection rates. Infect Control Hosp Epidemiol. 2004;25:313–8.PubMedCrossRef Brandt C, Hansen S, Sohr D, Daschner F, Ruden H, Gastmeier P. Finding a method for optimizing risk adjustment when comparing surgical-site infection rates. Infect Control Hosp Epidemiol. 2004;25:313–8.PubMedCrossRef
4.
Zurück zum Zitat Wilson J, Ward V, Coello R, Charlett A, Pearson A. A user evaluation of the Nosocomial Infection National Surveillance System: surgical site infection module. J Hosp Infect. 2002;52:114–21.PubMedCrossRef Wilson J, Ward V, Coello R, Charlett A, Pearson A. A user evaluation of the Nosocomial Infection National Surveillance System: surgical site infection module. J Hosp Infect. 2002;52:114–21.PubMedCrossRef
5.
Zurück zum Zitat Geubbels E, Grobbee D, Vandenbroucke-Grauls C, Wille J, de Boer A. Improved risk adjustment for comparison of surgical site infection rates. Infect Control Hosp Epidemiol. 2006;27:1330–9.PubMedCrossRef Geubbels E, Grobbee D, Vandenbroucke-Grauls C, Wille J, de Boer A. Improved risk adjustment for comparison of surgical site infection rates. Infect Control Hosp Epidemiol. 2006;27:1330–9.PubMedCrossRef
6.
Zurück zum Zitat Astagneau P, Rioux C, Golliot F, Bruker G. INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001;48:267–74.PubMedCrossRef Astagneau P, Rioux C, Golliot F, Bruker G. INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001;48:267–74.PubMedCrossRef
7.
Zurück zum Zitat Campbell D, Henderson W, Englesbe M, Hall B, O’Reilly M, Bratzler D, Dellinger E, et al. Surgical site infection prevention: the importance of operative duration and blood transfusion—results of the first American College of Surgeons—National Surgical Quality Improvement Program Best Practices initiative. J Am Coll Surg. 2008;207:810–20.PubMedCrossRef Campbell D, Henderson W, Englesbe M, Hall B, O’Reilly M, Bratzler D, Dellinger E, et al. Surgical site infection prevention: the importance of operative duration and blood transfusion—results of the first American College of Surgeons—National Surgical Quality Improvement Program Best Practices initiative. J Am Coll Surg. 2008;207:810–20.PubMedCrossRef
8.
Zurück zum Zitat Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70[Suppl 1]:11–6.PubMedCrossRef Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70[Suppl 1]:11–6.PubMedCrossRef
9.
Zurück zum Zitat Brümmer S, Brandt C, Sohr D, Gastmeier P. Does stratifying surgical site infection rates by the National Nosocomial Infection Surveillance risk index influence the rank order of the hospitals in a surveillance system. J Hosp Infect. 2008;69:295–300.PubMedCrossRef Brümmer S, Brandt C, Sohr D, Gastmeier P. Does stratifying surgical site infection rates by the National Nosocomial Infection Surveillance risk index influence the rank order of the hospitals in a surveillance system. J Hosp Infect. 2008;69:295–300.PubMedCrossRef
Metadaten
Titel
Prolonged duration of operation: an indicator of complicated surgery or of surgical (mis)management?
verfasst von
P. Gastmeier
D. Sohr
A. Breier
M. Behnke
C. Geffers
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 3/2011
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0112-x

Weitere Artikel der Ausgabe 3/2011

Infection 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.